Sofie
Clinical trials sponsored by Sofie, explained in plain language.
-
New imaging agent could sharpen cancer detection in gut tumors
Diagnosis CompletedThis study tested a new PET imaging agent called [18F]FAPI-74 in 109 people with gastrointestinal cancers, including liver, bile duct, stomach, pancreas, and colorectal cancers. The goal was to see if the scan could accurately find cancer cells by targeting a protein called FAP. …
Phase: PHASE2 • Sponsor: SOFIE • Aim: Diagnosis
Last updated May 26, 2026 04:35 UTC
-
New scan could spot pancreatic cancer more accurately
Diagnosis CompletedThis study tested a special PET scan that uses a tracer called [68Ga]FAPI-46 to find pancreatic cancer cells. 58 adults with early-stage pancreatic cancer received the scan before surgery. The goal was to see how well the scan detects cancer compared to standard methods. This cou…
Phase: PHASE2 • Sponsor: SOFIE • Aim: Diagnosis
Last updated May 26, 2026 04:34 UTC